thiotepa riemser
esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastické činidlá - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
nexgard combo
boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - mačky - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. veterinárneho lieku je výlučne uvedená pri všetkých troch skupín sú zamerané na rovnaký čas.
kapruvia
vifor fresenius medical care renal pharma france - difelikefalin - pruritus - všetky ostatné terapeutické produkty - kapruvia is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.
casaro hct 32 mg/12,5 mg
medreg s.r.o., Česká republika - kandesartan a diuretiká - 58 - hypotensiva
casaro hct 16 mg/12,5 mg
medreg s.r.o., Česká republika - kandesartan a diuretiká - 58 - hypotensiva
sotyktu
bristol-myers squibb pharma eeig - deucravacitinib - svrab - imunosupresíva - treatment of moderate-to-severe plaque psoriasis in adults.
ebglyss
almirall, s.a. - lebrikizumab - dermatitída, atopická - ostatné dermatologické prípravky - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.
linagliptin viatris
viatris limited, Írsko - linagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
ilinpru 5 mg
viatris limited, Írsko - linagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)